‘Haaretz’ Corrects Forced-Contraception Story
Over a month too late, an explosive story loses its bite
There was no shortage of outrage following a report by Haaretz in late Janaury asserting that Israel had acknowledged a policy of forcing long-acting birth control shots upon Ethiopian women in transit camps who wished to emigrate from Ethiopia to Israel. The story also charged that Israeli officials hadn’t told the women the effects of the Depo-Provera shots. The explosive first of the story went like this:
A government official has for the first time acknowledged the practice of injecting women of Ethiopian origin with the long-acting contraceptive Depo-Provera.
Beyond the normal outlets that selectively focus on Israeli scandals, sites that report on women’s issues reprinted the Haaretz story and, in multiple acts of stenographic journalism, cast their vicious judgments of Israeli racism and sexism to their readerships.
The first problem with the story: No Israeli official ever acknowledged there was such a practice at all; it was denied by Joint Distribution Committe, which ran the clinics, and the Health Ministry. (The Scroll was able to convince the popular site Jezebel to retract a damning first line after the story had already blown up and commenters had accused Israel of committing genocide.)
After an Israeli committee was established to investigate the matter, a second story ran in Haaretz last week repeating much of its original reporting. Then, earlier this week, came this correction (compelled by CAMERA):
This article, which was updated on March 6, 2013, reported on Health Ministry director-general Prof. Roni Gamzu’s instruction to gynecologists not to renew prescriptions for Depo-Provera if there is any doubt that recipients did not understand the implications of the treatment. The original version failed to state that this instruction was issued “without taking a stand or determining facts about allegations that had been made,” and referred to all women and not just women of Ethiopian origin.
So not only had the head of the Health Ministry not admitted the practice, he had–of his own volition and not under duress from scandal–issued a directive for doctors to make sure that all women (and not just Ethiopian women in transit camps) fully understood what the shots would do.
At this point, I have really no idea where the truth is in this highly unnerving and disquieting story, but the distance from where the story started and where it is now is unacceptable. We can give Haaretz credit for issuing a correction at all, but the amount of damage this story has done to Israel’s reputation will never be fully known.
The unprecedented $42 million buy was led by Treasurer Josh Mandel
Daily rate: $2
Monthly rate: $18
Yearly rate: $180
WAIT, WHY DO I HAVE TO PAY TO COMMENT?
Tablet is committed to bringing you the best, smartest, most enlightening and entertaining reporting and writing on Jewish life, all free of charge. We take pride in our community of readers, and are thrilled that you choose to engage with us in a way that is both thoughtful and thought-provoking. But the Internet, for all of its wonders, poses challenges to civilized and constructive discussion, allowing vocal—and, often, anonymous—minorities to drag it down with invective (and worse). Starting today, then, we are asking people who'd like to post comments on the site to pay a nominal fee—less a paywall than a gesture of your own commitment to the cause of great conversation. All proceeds go to helping us bring you the ambitious journalism that brought you here in the first place.
I NEED TO BE HEARD! BUT I DONT WANT TO PAY.
Readers can still interact with us free of charge via Facebook, Twitter, and our other social media channels, or write to us at email@example.com. Each week, we’ll select the best letters and publish them in a new letters to the editor feature on the Scroll.
We hope this new largely symbolic measure will help us create a more pleasant and cultivated environment for all of our readers, and, as always, we thank you deeply for your support.